Stocks
AstraZeneca PLC (AZN) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 20.2% | 12.5% | 21.0% | 19.5% | 28.3% | 32.3% | ||
| Changes by years, y/y, % | -8pp | -8pp | +9pp | -2pp | +9pp | -2.7% | |||
AstraZeneca PLC. EBITDA margin, %
AstraZeneca PLC. EBITDA margin, changes, pp
AstraZeneca PLC (AZN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 22.2% | 35.5% | 31.9% | 31.8% | 30.2% | 32.3% | |
| Changes by years, y/y, % | +12pp | 0pp | -1pp | -1pp | +1pp | |||
| Changes by quarters, q/q, % | -14pp | +13pp | -4pp | 0pp | -2pp | |||
